Our patient population included men with type 2 diabetes and the metabolic syndrome, and in a separate analysis we showed that neither condition affected myocardial structure, microvasculature, or expression of CML and RAGE, apart from reduced perivascular fibrosis of diabetic and metabolic syndrome patients [22]. This evidence concerns the gene AGER and chronic myelogenous leukemia, BCR-ABL1 positive.